These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 34385068)
21. The use of fluorine-18-fluorodeoxyglucose-positron emission tomography/computed tomography as an effective method for staging in dogs with primary appendicular osteosarcoma. Crooks C; Randall E; Griffin L Vet Radiol Ultrasound; 2021 May; 62(3):350-359. PubMed ID: 33629412 [TBL] [Abstract][Full Text] [Related]
22. The Value of 18F-FDG PET/CT in Detecting Bone Marrow Involvement in Childhood Cancers. Yağci-Küpeli B; Koçyiğit-Deveci E; Adamhasan F; Küpeli S J Pediatr Hematol Oncol; 2019 Aug; 41(6):438-441. PubMed ID: 31033787 [TBL] [Abstract][Full Text] [Related]
23. Comparison of (18) F-FDG-PET-CT and Bone Scintigraphy for Evaluation of Osseous Metastases in Newly Diagnosed and Recurrent Osteosarcoma. Hurley C; McCarville MB; Shulkin BL; Mao S; Wu J; Navid F; Daw NC; Pappo AS; Bishop MW Pediatr Blood Cancer; 2016 Aug; 63(8):1381-6. PubMed ID: 27082077 [TBL] [Abstract][Full Text] [Related]
24. Comparative study of FDG PET/CT and conventional imaging in the staging of rhabdomyosarcoma. Tateishi U; Hosono A; Makimoto A; Nakamoto Y; Kaneta T; Fukuda H; Murakami K; Terauchi T; Suga T; Inoue T; Kim EE Ann Nucl Med; 2009 Feb; 23(2):155-61. PubMed ID: 19225939 [TBL] [Abstract][Full Text] [Related]
25. The diagnostic and prognostic value of ¹⁸F-FDG PET/CT in the initial assessment of high-grade bone and soft tissue sarcoma. A retrospective study of 89 patients. Fuglø HM; Jørgensen SM; Loft A; Hovgaard D; Petersen MM Eur J Nucl Med Mol Imaging; 2012 Sep; 39(9):1416-24. PubMed ID: 22699526 [TBL] [Abstract][Full Text] [Related]
26. European guideline for imaging in paediatric and adolescent rhabdomyosarcoma - joint statement by the European Paediatric Soft Tissue Sarcoma Study Group, the Cooperative Weichteilsarkom Studiengruppe and the Oncology Task Force of the European Society of Paediatric Radiology. van Ewijk R; Schoot RA; Sparber-Sauer M; Ter Horst SAJ; Jehanno N; Borgwardt L; de Keizer B; Merks JHM; de Luca A; McHugh K; von Kalle T; Schäfer JF; van Rijn RR; Pediatr Radiol; 2021 Sep; 51(10):1940-1951. PubMed ID: 34137936 [TBL] [Abstract][Full Text] [Related]
27. Comparison of the diagnostic accuracy of 99 m-Tc-MDP bone scintigraphy and 18 F-FDG PET/CT for the detection of skeletal metastases. Chang CY; Gill CM; Joseph Simeone F; Taneja AK; Huang AJ; Torriani M; Bredella MA Acta Radiol; 2016 Jan; 57(1):58-65. PubMed ID: 25533313 [TBL] [Abstract][Full Text] [Related]
28. Bone marrow examination in patients with Ewing sarcoma/peripheral primitive neuroectodermal tumor without metastasis based on Inagaki C; Shimoi T; Sumiyoshi Okuma H; Kawachi A; Sudo K; Shimomura A; Noguchi E; Kodaira M; Yunokawa M; Yonemori K; Shimizu C; Arakawa A; Ogawa C; Yoshida A; Fujiwara Y; Tamura K Med Oncol; 2019 May; 36(7):58. PubMed ID: 31104192 [TBL] [Abstract][Full Text] [Related]
29. Diagnostic value of Kassem TW; Abdelaziz O; Emad-Eldin S Diagn Interv Imaging; 2017 Oct; 98(10):693-698. PubMed ID: 28734778 [TBL] [Abstract][Full Text] [Related]
30. FDG PETCT for assessing marrow involvement at staging pediatric nonhematological round cell malignancies. Shah S; Purandare N; Kembhavi S; Puranik A; Agrawal A; Bedmutha A; Qureshi S; Chinnaswamy G; Vora T; Prasad M; Parambil B; Rangarajan V Nucl Med Commun; 2022 Jan; 43(1):56-63. PubMed ID: 34618718 [TBL] [Abstract][Full Text] [Related]
31. Is methylene diphosphonate bone scan necessary for initial staging of Ewing sarcoma if 18F-FDG PET/CT is performed? Ulaner GA; Magnan H; Healey JH; Weber WA; Meyers PA AJR Am J Roentgenol; 2014 Apr; 202(4):859-67. PubMed ID: 24660717 [TBL] [Abstract][Full Text] [Related]
33. Can FDG-PET/CT replace blind bone marrow biopsy of the posterior iliac crest in Ewing sarcoma? Kasalak Ö; Glaudemans AWJM; Overbosch J; Jutte PC; Kwee TC Skeletal Radiol; 2018 Mar; 47(3):363-367. PubMed ID: 29124298 [TBL] [Abstract][Full Text] [Related]
34. The role of 18F-FDG PET/CT in staging and restaging primary bone lymphoma. Liu Y Nucl Med Commun; 2017 Apr; 38(4):319-324. PubMed ID: 28225435 [TBL] [Abstract][Full Text] [Related]
35. Bosma SE; Vriens D; Gelderblom H; van de Sande MAJ; Dijkstra PDS; Bloem JL Skeletal Radiol; 2019 Nov; 48(11):1735-1746. PubMed ID: 31016339 [TBL] [Abstract][Full Text] [Related]
36. Liu C; Gong C; Liu S; Zhang Y; Zhang Y; Xu X; Yuan H; Wang B; Yang Z Oncologist; 2019 Dec; 24(12):e1277-e1285. PubMed ID: 31337657 [TBL] [Abstract][Full Text] [Related]
37. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment. Bastiaannet E; Wobbes T; Hoekstra OS; van der Jagt EJ; Brouwers AH; Koelemij R; de Klerk JM; Oyen WJ; Meijer S; Hoekstra HJ J Clin Oncol; 2009 Oct; 27(28):4774-80. PubMed ID: 19720925 [TBL] [Abstract][Full Text] [Related]
39. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients. Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912 [TBL] [Abstract][Full Text] [Related]
40. Comparative effectiveness: 18F-FDG-PET/CT versus CT for post-treatment follow-up of patients with lung cancer. Sheikhbahaei S; Ahn SJ; Young B; Taghipour M; Marcus C; Subramaniam RM Nucl Med Commun; 2017 Aug; 38(8):720-725. PubMed ID: 28678114 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]